Round led by Lumira Ventures and Roche Venture Fund with new investment from SanofiCHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- COUR Pharma, a clinical-stage biotechnology company developing ...
Natera, Inc. , a global leader in cell-free DNA and precision medicine, and Aveta Biomics, Inc., a clinical-stage immuno-oncology company advancing first-in-class oral immunotherapies for solid tumors ...
The gut microbiome is not a mere spectator but an active player in colorectal cancer (CRC), driving tumor initiation and ...
Two Danville families are betting big on ostriches as a safe alternative for Alpha-Gal Syndrome sufferers as the tick-borne illness spreads.
People with obesity and type 2 diabetes are at high risk of blood vessel damage. This risk depends not only on the genes a person carries, but also ...
The Hearty Soul on MSN
Common anemia medication shows unexpected potential in cancer treatment
New 2026 research from Finland finds HIF-PHI anemia medications may slow cancer cell growth and block tumor blood vessels ...
Test time has arrived: the first person has been treated in a highly anticipated gene-therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial is testing an ...
The next step in the youth quest is a technology called chemical reprogramming. The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...
A homeschooling center in Manhattan is part of the company’s nationwide expansion. Internal documents reveal its strategy: “Opening date > safety.” In the fall of 2025, top executives from Alpha ...
Explore why SpaceX is a Strong Buy and Tesla, Inc. a Buy, why a merger could destroy value, and how to allocate 1–5% in your ...
Traditional cancer treatments like chemotherapy and radiotherapy can induce immunogenic cell death (ICD), but their efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results